Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Petros Pharmaceuticals, Inc. (PTPI) vs Redhill Biopharma Ltd. (RDHL)

Petros Pharmaceuticals, Inc. and Redhill Biopharma Ltd. are both Drug Manufacturers Specialty & Generic companies. Redhill Biopharma Ltd. is the larger, with a market value of $3.2M against $1.0M — 3.1× the size. Petros Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 36.1% against −61.9%. Redhill Biopharma Ltd. has the higher net margin (25.2% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Petros Pharmaceuticals, Inc. leads on 7 and Redhill Biopharma Ltd. on 5.

Valuation

Metric PTPI RDHL Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S n/m 0.32 2.25
P/B n/m n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales 0.34 0.30 2.56
Earnings yield 0.00% (122,133.34%) (2.99%)
Free cash flow yield 0.00% (909.75%) 0.00%

Profitability

Metric PTPI RDHL Drug Manufacturers Specialty & Generic median
Gross margin 76.35% 35.16% 53.94%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 25.20% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (710.28%) 0.00% (0.40%)
Return on assets (334.15%) 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PTPI RDHL Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 36.07% (61.93%) 10.01%
EPS growth (last fiscal year) 98.13% 97.91% —
Revenue growth, 5-year CAGR (19.98%) (66.15%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PTPI RDHL Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.05
Current ratio 1.25 0.56 2.31
Net debt to EBITDA 1.11 0.53 0.85

Dividend

Metric PTPI RDHL Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric PTPI RDHL Drug Manufacturers Specialty & Generic median
Market cap 1.04m 3.22m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack